SOST Polymorphisms and Response to Alendronate Treatment in Postmenopausal Chinese Women With Osteoporosis
Authors:
Open Access
- 1 July 2015
- journal article
- research article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 16 (10) , 1077-1088
Abstract
Aim: To investigate the association between SOST gene polymorphisms and response to alendronate treatment. Materials & methods: 639 Chinese postmenopausal women with osteoporosis or osteopenia received alendronate treatment. Polymorphisms of SOST were analyzed. Bone mineral density (BMD), serum ALP and β-CTX levels were measured. The correlation of SOST polymorphisms with changes of BMD and bone biomarkers after treatment was analyzed. Results: rs1234612 and rs851054 polymorphisms were correlated to baseline lumbar spine BMD (p < 0.05). After 12 months of treatment rs1234612 and rs865429 polymorphisms were correlated to BMD changes at the lumbar spine (p < 0.05) or femoral neck (p < 0.05), respectively. Conclusion: The polymorphisms of SOST are genetic factors affecting bone health and response to alendronate in Chinese postmenopausal women.Keywords
Funding Information
- The China National Scientific & Technological Pillar (2006BAI02B03)
- National Science Foundation (81100623)
This publication has 37 references indexed in Scilit:
- LRP5 Polymorphisms and Response to Alendronate Treatment in Chinese Postmenopausal Women With OsteoporosisPharmacogenomics, 2014
- Factors associated with bisphosphonate treatment failure in postmenopausal women with primary osteoporosisOsteoporosis International, 2014
- Genetic determinants of heel bone properties: genome-wide association meta-analysis and replication in the GEFOS/GENOMOS consortiumHuman Molecular Genetics, 2014
- The association between polymorphisms in Wnt antagonist genes and bone response to hormone therapy in postmenopausal Korean womenMenopause, 2012
- Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fractureNature Genetics, 2012
- The effect of vitamin D receptor BsmI genotype on the response to osteoporosis treatment in postmenopausal women: A pilot studyJournal of Obstetrics and Gynaecology Research, 2011
- Pharmacogenetics of Osteoporosis: Future PerspectivesCalcified Tissue International, 2009
- Multiple Genetic Loci for Bone Mineral Density and FracturesNew England Journal of Medicine, 2008
- Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association studyThe Lancet, 2008
- Osteoporosis Prevention, Diagnosis, and TherapyJAMA, 2001